Metraipolis › archive › dc_84b6e2cc2c23

Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction — Europe PMC PMID:41958458

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41958458
DOI
10.3389/fcvm.2026.1753965
License (as archived)
solo-consultazione
Archived
2026-11-03T22:20:45.818Z
SHA-256 of the archived text
6de4a9ee47205e43afaafc85cb3c2d6f181898bdba9b56c36f900e3cd11ffcf7
Stable URL of this page
https://metraipolis.com/documento/dc_84b6e2cc2c23

How to cite

Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction — Europe PMC PMID:41958458 — Europe PMC (en), https://europepmc.org/article/MED/41958458 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84b6e2cc2c23 (Metraipolis archive dc_84b6e2cc2c23, sha256 6de4a9ee47205e43afaafc85cb3c2d6f181898bdba9b56c36f900e3cd11ffcf7)
BibTeX
@misc{dc84b6e2cc2c23,
  title = {Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction — Europe PMC PMID:41958458},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41958458},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84b6e2cc2c23; sha256 6de4a9ee47205e43afaafc85cb3c2d6f181898bdba9b56c36f900e3cd11ffcf7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41958458. Agents can read the archived copy with the MCP tool read_document.